| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/09/2011 | WO2011011721A9 Compounds, compositions and methods for protecting brain health in neurodegenerative disorders |
| 06/09/2011 | WO2011009851A3 Walnut extracts for nutraceutical applications |
| 06/09/2011 | WO2010147969A3 Gamma secretase modulators |
| 06/09/2011 | US20110137013 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 06/09/2011 | US20110136914 Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity |
| 06/09/2011 | US20110136911 Treatment of sepsis and inhibition of mif by d-t4 |
| 06/09/2011 | US20110136892 Targeting TGF-beta as a Therapy for Alzheimer's Disease |
| 06/09/2011 | US20110136890 Treatment of fibrotic conditions |
| 06/09/2011 | US20110136888 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof |
| 06/09/2011 | US20110136886 Azabicyclo[3.2.0] hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them |
| 06/09/2011 | US20110136884 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 06/09/2011 | US20110136879 Compound |
| 06/09/2011 | US20110136869 Compounds Which Selectively Modulate The CB2 Receptor |
| 06/09/2011 | US20110136867 Treatment of Synucleinopathies |
| 06/09/2011 | US20110136865 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| 06/09/2011 | US20110136864 Tetrahydroquinoline indole derivatives and uses thereof |
| 06/09/2011 | US20110136863 N-Heterocyclic M1 Receptor Positive Allosteric Modulators |
| 06/09/2011 | US20110136862 Novel tetramethyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/09/2011 | US20110136860 Compounds |
| 06/09/2011 | US20110136859 Compounds |
| 06/09/2011 | US20110136857 Pyrrole[2,3-b]pyridine derivatives active as kinase inhibitors |
| 06/09/2011 | US20110136854 Novel 9-aza-bicyclo[3.3.1]non-3-yloxy chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/09/2011 | US20110136853 Ligand with a broad spectrum of pharmacological activity, a pharmaceutical composition, a medicinal agent and a method of treatment |
| 06/09/2011 | US20110136849 Process for reducing contaminating michael acceptor levels in oxycodone and other compositions |
| 06/09/2011 | US20110136848 Morphinan derivatives for the treatment of drug overdose |
| 06/09/2011 | US20110136846 Buprenorphine Analogs |
| 06/09/2011 | US20110136845 (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof |
| 06/09/2011 | US20110136844 Methods for inhibiting dyrk1a to treat central nervous system diseases and disorders |
| 06/09/2011 | US20110136842 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers |
| 06/09/2011 | US20110136839 Combination of two analgesic chemicals |
| 06/09/2011 | US20110136836 Methods for Altering MRNA Splicing and Treating Familial Dysautonomia and Other Mechanistically Related Disorders |
| 06/09/2011 | US20110136834 Inhibitors of e1 activating enzymes |
| 06/09/2011 | US20110136833 Tetrahydropyridinyl and Dihydropyrrolyl Compounds and the Use Thereof |
| 06/09/2011 | US20110136832 Promoting Cycling of ApoE4 Isoform |
| 06/09/2011 | US20110136828 Substituted n-oxide pyrazine derivatives |
| 06/09/2011 | US20110136825 Treatment of Vasomotor Symptoms |
| 06/09/2011 | US20110136824 Urotensin ii receptor antagonists |
| 06/09/2011 | US20110136813 Wnt protein signalling inhibitors |
| 06/09/2011 | US20110136808 3',6-substituted indirubins and their biological applications |
| 06/09/2011 | US20110136804 Nicotinic Acetylcholine Receptor Ligands 101 |
| 06/09/2011 | US20110136802 Ship1 modulators and methods related thereto |
| 06/09/2011 | US20110136798 Crystalline Forms Of A Pyridine Derivative |
| 06/09/2011 | US20110136797 Cyclopropyl amines as modulators of the histamine h3 receptor |
| 06/09/2011 | US20110136793 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs |
| 06/09/2011 | US20110136791 Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders |
| 06/09/2011 | US20110136790 Tricyclic Heterocyclic Derivatives and Methods of Use |
| 06/09/2011 | US20110136787 Diphenyl azepane, diazepane and oxazepane derivatives and uses thereof |
| 06/09/2011 | US20110136786 Method of treating mood disorders |
| 06/09/2011 | US20110136785 Method of treatment |
| 06/09/2011 | US20110136784 Method of Treating Anxiety Disorders |
| 06/09/2011 | US20110136783 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 06/09/2011 | US20110136780 Dihydropyrrolonaphtyridinone compounds as inhibitors of jak |
| 06/09/2011 | US20110136776 Copper(1)Chloride Complex of Nicotinic Acid and Pharmaceutical Compositions Containing the Same |
| 06/09/2011 | US20110136774 Anti-Apoptotic Benzodiazepine Receptor Ligand Inhibitors |
| 06/09/2011 | US20110136765 Pyrrolo[2,3-D]Pyrimidine Compounds |
| 06/09/2011 | US20110136750 Compounds useful for treating neurodegenerative disorders |
| 06/09/2011 | US20110136749 Compounds useful for treating neurodegenerative disorders |
| 06/09/2011 | US20110136742 Antidepressant prodrugs |
| 06/09/2011 | US20110136738 Alternatively Transcribed Genes Associated with Schizophrenia |
| 06/09/2011 | US20110136733 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110136725 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| 06/09/2011 | US20110136724 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110135745 Drink formula comprising fresh marine omega-3 oil and antioxidants |
| 06/09/2011 | US20110135731 Abuse-resistant opioid dosage form |
| 06/09/2011 | US20110135706 Nerve treatment devices and methods |
| 06/09/2011 | US20110135696 Multipotent neural cells |
| 06/09/2011 | US20110135678 Tolerizing agents |
| 06/09/2011 | US20110135673 Epitope protection assay |
| 06/09/2011 | US20110135664 Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration |
| 06/09/2011 | US20110135660 Prevention and treatment of synucleinopathic disease |
| 06/09/2011 | US20110135652 Novel Use of Idbf |
| 06/09/2011 | US20110135644 Methods and compositions for enhanced delivery of macromolecules |
| 06/09/2011 | US20110135632 Methods for the modulation of angiogenesis |
| 06/09/2011 | US20110135623 Conjugates of a Cholinesterase Moiety and a Polymer |
| 06/09/2011 | US20110135613 Methods for treating apolipoprotein e4-associated disorders |
| 06/09/2011 | US20110135612 Compositions to effect neuronal growth |
| 06/09/2011 | US20110135611 Methods for treating apolipoprotein e4-associated disorders |
| 06/09/2011 | US20110135607 Viral nucleic acid for the treatment of neurodegenerative disorders |
| 06/09/2011 | US20110135602 Supperssor of the endogenous interferon-gamma |
| 06/09/2011 | US20110135594 Oxindolyl inhibitor compounds |
| 06/09/2011 | CA2782727A1 2-pyridone compounds |
| 06/09/2011 | CA2782704A1 Diphenyl-pyrazolopyrdine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators |
| 06/09/2011 | CA2782625A1 Treatment of allodynia and hyperalgesia |
| 06/09/2011 | CA2782556A1 Amantadine compositions and methods of use |
| 06/09/2011 | CA2782529A1 Morphinan derivatives for the treatment of drug overdose |
| 06/09/2011 | CA2782459A1 Arf6 as a new target for treating alzheimer's disease |
| 06/09/2011 | CA2782314A1 Method of treatment of cns disorders |
| 06/09/2011 | CA2782240A1 Formulations, salts and polymorphs of transnorsertraline and uses thereof |
| 06/09/2011 | CA2781716A1 Multicyclic compounds and methods of use thereof |
| 06/09/2011 | CA2724151A1 Novel derivatives of azabicyclo[3.2.0]hept-3-yl, their preparation process and the pharmaceutical compounds that contain them |
| 06/08/2011 | EP2330219A2 Method for drug discovery, disease treatment and diagnosis using metabolomics |
| 06/08/2011 | EP2330194A2 Non-sequence complementary antiviral oligonucleotides |
| 06/08/2011 | EP2330193A1 Improved antibody molecule |
| 06/08/2011 | EP2330187A2 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseases |
| 06/08/2011 | EP2330099A1 Novel salt of morpholine derivative |
| 06/08/2011 | EP2329842A2 Interleukin-1 inhibitors in the treatment of diseases |
| 06/08/2011 | EP2329829A2 Use of uridine in combination with choline for the treatment of memory disorders |
| 06/08/2011 | EP2329824A1 Novel pharmaceutical composition for treatment of nociceptive pain |
| 06/08/2011 | EP2329723A1 Fruit and/or vegetable derived composition |
| 06/08/2011 | EP2329714A1 Influence of TAJ in the neuronal functions |